Address: Insure Insights 61 Bridge Street, Kington.HR5 3DJ United Kingdom

Global Oncology Drugs Market Outlook 2028: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028

  • Home
  • Reports
  • Global Oncology Drugs Market Outlook 2028: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028
Global Oncology Drugs Market Outlook 2028: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028

Global Oncology Drugs Market Outlook 2028: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028

  • Published Date: 22 Nov 2020
  • Report ID: HLT 0038
  • Pages:194
  • Base Year: 2019
  • Format: PDF
  • Historical Data: 2016-2019

Oncology Drugs Market is anticipated to grow with a value CAGR of 7.3% over 2019-2028. According to a study published by Insure Insights on the Oncology Drugs Market, Oncology means to study and treatments of cancers, Oncology drugs are those drugs used in the treatment of Cancers. An increase in Government spending for better healthcare an increase in awareness among people about cancer are expanding the market growth.

Top Driver: The Rise in the Incidence of Cancer and Technological advances are making a significant contribution to the Market

There has been a significant rise in the incidence of cancer, Rise in the number of smoker globally is boosted the demand in the Market. There have been noteworthy technological advances in the treatment of Cancer; immunology is one of those advances for instance Avalon GloboCare Corp in May 2020 had announced that they are advancing its next-generation immune cell therapy using FLASH-CAR technology co-developed with the Company’s strategic partner Arbele Limited. FLASH-CAR platform could be used to create personalized cell therapy from a patient’s own cells, as well as off-the-shelf cell therapy from a universal donor; This treatment was especially for the treatment of Blood cancer

Targeted Therapy is obtained the highest growth in the  Global Oncology Drugs Market

Based on Treatment, Targeted Therapy has obtained the most significant growth in the Oncology Drugs Market. Targeted Therapy has gained a lot of importance as it only Kills the malignant cancerous cell; it also assures high survival rates and also high efficacy. For instance, In May 2020 FDA had approved YNPARZA, which now brings a molecularly targeted treatment to men with HRR gene-mutated metastatic castration-resistant prostate cancer in the U.S. In terms of indication segment prostate cancer has obtained the most remarkable growth as there has been a significant rise in the geriatric population.

 Asia pacific to rule the Regional Market due to the rise in the awareness among people

The Rise in the awareness among people, Increased per capita income in the developing countries is boosting the regional growth of the Market. The Rise in Government spending, favorable reimbursement for advanced healthcare, Increased R&D expenditure, are expanding the market growth in the Market. Technological advances in various therapies rise in the geriatric population are further escalating the market growth. Lifestyle changes, Rise in the number of smokers globally is further boosted the market growth.

 

Players to Focus on advancing the technologies for enhancing the treatment activities

The Competitors are focusing on developing new technologies for enhancing the treatment capabilities. The major competitors of the Oncology Drugs Market are F. Hoffmann-La Roche Ltd., Novartis AG, Johnson & Johnson, Pfizer, Inc., Bristol–Myers Squibb, AstraZeneca PLC, GlaxoSmithKline plc, Eli Lilly and Company, Amgen Inc., and, Sanofi

  1. Hoffmann-La Roche Ltd: F. Hoffmann-La Roche Ltd is the leading competitor of the Oncology Drugs Market. For instance in 4 March 2020 had announced that the U.S. Food and Drug Administration (FDA), had approved the as Breakthrough Device Designation to the Elecsy GALAD score; it is intended to be used for the diagnosis of early-stage hepatocellular carcinoma (HCC). The regulatory approval was obtained for use in in Vitro Diagnostics and is an integral part of the Roche Diagnostics Liver Indication Program. Hoffmann-La Roche Limited had announced in April 2020 Health Canada, under the Notice of Compliance with Conditions, has approved Rozlytrek  (entrectinib) for adults with unresectable locally advanced or metastatic extracranial solid tumors, including brain metastases.

Novartis AG : Novartis AG is one of the popular competitor of the Oncology Drugs Market and are also doing many reaserches to develop promising drug for cancer treatments. In May 2020, Novartis had announced that the exploratory subgroup analysis of the Phase III MONALEESA-3 and MONALEESA-7 trials for the treatment of breast cancer, the results of the trails proved to be promising and have helped in the overall survival (O.S.) benefit of Kisqali (ribociclib).

Scope of the Report

By Drug Type

  • Chemotherapy
  • Immunotherapy
  • Targeted Therapy
  • Others

By Indication

  • Lung Cancer
  • Stomach Cancer
  • Prostate Cancer
  • Others

By Region

  • North America
  • Europe
  • Asia Pacific
  • LAMEA

Chapter 1          Overview And Scope

1.1            Market Vision

1.1.1        Market Definition

1.1.2        Market Scope

1.2            Market Segmentation

Chapter 2          Our Research Practice

2.1            Our Research Methodology

2.2            Data Triangulation

2.3            Data Sources

2.4            Assumptions for the study

2.5            Approach Adopted

Chapter 3          Executive Summary

3.1            Market Snapshot

3.2            Regional Snapshot

3.3            Segment Summary

Chapter 4          Covid-19 Impact Analysis

4.1            Overview

4.2            Prevalence analysis

4.3            Key Factor Impact Analysis

Chapter 5          Global Sleep Apnea Devices Market Forces

5.1            What’s Driving the Market

5.2            Porter’s Five Forces Analysis

5.2.1        Power of Suppliers

5.2.2        Threats From New Entrants

5.2.3        Power of Buyer

5.2.4        Threat From Substitute Product

5.2.5        Degree of Competition

Chapter 6          Global Sleep Apnea Devices Market -Industry Snapshots

6.1            Overview

6.1.1        Global Sleep Apnea Devices Market Value, 2019 – 2028, (US$ Bn)

6.2            Market Overview

6.2.1        Drivers Analysis

6.2.2        Restraint/Challenges analysis

6.2.3        Opportunity Analysis

6.3            Supply Chain/Value Chain Analysis

6.4            Market SWOT Analysis

Chapter 7          Global Sleep Apnea Devices Market Analysis, by Diagnostic Devices

7.1            Overview

7.2            Key Findings for Sleep Apnea Devices Market- By Diagnostic Devices

7.2.1        Sleep Apnea Devices Market- Pulse oximeters

7.2.2        Sleep Apnea Devices Market- Actigraphy devices

7.2.3        Sleep Apnea Devices Market- Polysomnography Devices

Chapter 8          Global Sleep Apnea Devices Market Analysis, by Therapeutic Devices

8.1            Overview

8.2            Key Findings for Sleep Apnea Devices Market- By Therapeutic Devices

8.2.1        Sleep Apnea Devices Market- Oxygen Devices

8.2.2        Sleep Apnea Devices Market- Positive Airways Pressure Devices

8.2.3        Sleep Apnea Devices Market- Oral Appliances

8.2.4        Sleep Apnea Devices Market- Others

Chapter 9          Sleep Apnea Devices Market Analysis by Region

9.1            Key Findings for Sleep Apnea Devices Market- By region

9.2            Overview

9.2.1        Global Sleep Apnea Devices Market Analysis, By Diagnostic Devices, 2019 – 2028

9.2.2        Global Sleep Apnea Devices Market Analysis, By Therapeutic Devices, 2019 – 2028

9.3            Sleep Apnea Devices Market – North America

9.3.1        Overview

9.3.2        U.S.

9.3.3        Canada

9.3.4        Mexico

9.3.5        North America Market, By Diagnostic Devices

9.3.6        North America Market, By Therapeutic Devices

9.4            Sleep Apnea Devices Market – Europe

9.4.1        Overview

9.4.2        Germany

9.4.3        United Kingdom

9.4.4        France

9.4.5        Italy

9.4.6        Rest Of Europe

9.4.7        Europe Market, By Diagnostic Devices

9.4.8        Europe Market, By Therapeutic Devices

9.5            Sleep Apnea Devices Market – Asia Pacific

9.5.1        Overview

9.5.2        China

9.5.3        Japan

9.5.4        India

9.5.5        Rest of APAC

9.5.6        Asia Pacific Market, By Diagnostic Devices

9.5.7        Asia Pacific Market, By Therapeutic Devices

9.6            Sleep Apnea Devices Market – SAMEA

9.6.1        Overview

9.6.2        Middle East & Africa (MEA)

9.6.3        South America

9.6.4        Rest Of World

9.6.5        South America, Middle East and Africa Market, By Diagnostic Devices

9.6.6        South America, Middle East and Africa Market, By Therapeutic Devices

Chapter 10      Market Competition Analysis

10.1          Market Share/Positioning Analysis

10.1.1      Market Positioning of Key Vendors, 2019

10.1.2      Key Strategies Adopted by the Leading Players

10.1.3      Recent Developments

Chapter 11      Company Profiles- Snapshot

11.1          Curative Medical Inc

11.1.1      Business Fundamentals

11.1.2      Financial Snapshots

11.1.3      Product Portfolio

11.1.4      Recent Developments

11.2          Philips Respironics

11.3          ResMed

11.4          Fisher & Paykel Healthcare

11.5          Cadwell Laboratories

11.6          Invacare Corporation

*More than 10 Companies are profiled in this Research Report*

*Financials would be provided on a best efforts basis for private companies”

Chapter 12      Appendix

List of Figures

 

FIG. 1          Global Sleep Apnea Devices: Market Segmentation

FIG. 2          Global Sleep Apnea Devices Market: Research Methodology

FIG. 3          Top-Down and Bottom Up Approach

FIG. 4          Market Snapshot

FIG. 5          Porter’s Five Forces Analysis

FIG. 6          Global Sleep Apnea Devices Market Value, 2019 – 2028, (US$ Bn)

FIG. 7          Supply Chain/Value Chain Analysis

FIG. 8          Global Sleep Apnea Devices Market Value Contribution, By Diagnostic Devices, 2019 & 2026 (%)

FIG. 9          Global Sleep Apnea Devices Market Value Contribution, By Therapeutic Devices, 2019 & 2026 (%)

FIG. 10        Global Sleep Apnea Devices Market Value, 2019 – 2028, (US$ Bn)

FIG. 11        North America Sleep Apnea Devices Market Value, 2019 – 2028, (US$ Bn)

FIG. 12        Sleep Apnea Devices Market Segment 1 – North America

FIG. 13        Sleep Apnea Devices Market Segment 2 – North America

FIG. 14        Sleep Apnea Devices U.S. outlook, 2019 & 2026

FIG. 15        Sleep Apnea Devices Canada outlook, 2019 & 2026

FIG. 16        Sleep Apnea Devices Mexico outlook, 2019 & 2026

FIG. 17        Europe Sleep Apnea Devices Market Value, 2019 – 2028, (US$ Bn)

FIG. 18        Sleep Apnea Devices Market Segment 1 – Europe

FIG. 19        Sleep Apnea Devices Market Segment 2 – Europe

FIG. 20        Sleep Apnea Devices Germany outlook, 2019 & 2026

FIG. 21        Sleep Apnea Devices United Kingdom outlook, 2019 & 2026

FIG. 22        Sleep Apnea Devices France outlook, 2019 & 2026

FIG. 23        Sleep Apnea Devices Italy outlook, 2019 & 2026

FIG. 24        Sleep Apnea Devices Rest Of Europe outlook, 2019 & 2026

FIG. 25        Asia Pacific Sleep Apnea Devices Market Value, 2019 – 2028, (US$ Bn)

FIG. 26        Sleep Apnea Devices Market Segment 1 – Asia Pacific

FIG. 27        Sleep Apnea Devices Market Segment 2 – Asia Pacific

FIG. 28        Sleep Apnea Devices China outlook, 2019 & 2026

FIG. 29        Sleep Apnea Devices Japan outlook, 2019 & 2026

FIG. 30        Sleep Apnea Devices India outlook, 2019 & 2026

FIG. 31        Sleep Apnea Devices Rest of APAC outlook, 2019 & 2026

FIG. 32        SAMEA Sleep Apnea Devices Market Value, 2019 – 2028, (US$ Bn)

FIG. 33        Sleep Apnea Devices Market Segment 1 – SAMEA

FIG. 34        Sleep Apnea Devices Market Segment 2 – SAMEA

FIG. 35        Sleep Apnea Devices Middle East & Africa (MEA) outlook, 2019 & 2026

FIG. 36        Sleep Apnea Devices South America outlook, 2019 & 2026

FIG. 37        Sleep Apnea Devices Rest Of World outlook, 2019 & 2026

 

List of Tables

 

TABLE 1      Sleep Apnea Devices market by Diagnostic Devices 1, 2019 – 2028 (USD Million)

TABLE 2      Sleep Apnea Devices market by Diagnostic Devices 2, 2019 – 2028 (USD Million)

TABLE 3      Sleep Apnea Devices market by Diagnostic Devices 3, 2019 – 2028 (USD Million)

TABLE 4      Sleep Apnea Devices market by Therapeutic Devices 1, 2019 – 2028 (USD Million)

TABLE 5      Sleep Apnea Devices market by Therapeutic Devices 2, 2019 – 2028 (USD Million)

TABLE 6      Sleep Apnea Devices market by Therapeutic Devices 3, 2019 – 2028 (USD Million)

TABLE 7      Sleep Apnea Devices market by Therapeutic Devices 4, 2019 – 2028 (USD Million)

TABLE 8      Global Sleep Apnea Devices Market Value, By Diagnostic Devices, 2019 – 2028 (US$ Bn)

TABLE 9      Global Sleep Apnea Devices Market Value, By Therapeutic Devices, 2019 – 2028 (US$ Bn)

TABLE 10   Sleep Apnea Devices Market Analysis by North America (USD Million), 2019 – 2028

TABLE 11   U.S. Sleep Apnea Devices Market, 2019 – 2028 (USD Million)

TABLE 12   U.S. Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)

TABLE 13   U.S. Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)

TABLE 14   Canada Sleep Apnea Devices Market, 2019 – 2028 (USD Million)

TABLE 15   Canada Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)

TABLE 16   Canada Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)

TABLE 17   Mexico Sleep Apnea Devices Market, 2019 – 2028 (USD Million)

TABLE 18   Mexico Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)

TABLE 19   Mexico Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)

TABLE 20   Sleep Apnea Devices Market Analysis by Europe (USD Million), 2019 – 2028

TABLE 21   Germany Sleep Apnea Devices Market, 2019 – 2028 (USD Million)

TABLE 22   Germany Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)

TABLE 23   Germany Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)

TABLE 24   United Kingdom Sleep Apnea Devices Market, 2019 – 2028 (USD Million)

TABLE 25   United Kingdom Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)

TABLE 26   United Kingdom Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)

TABLE 27   France Sleep Apnea Devices Market, 2019 – 2028 (USD Million)

TABLE 28   France Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)

TABLE 29   France Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)

TABLE 30   Italy Sleep Apnea Devices Market, 2019 – 2028 (USD Million)

TABLE 31   Italy Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)

TABLE 32   Italy Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)

TABLE 33   Rest Of Europe Sleep Apnea Devices Market, 2019 – 2028 (USD Million)

TABLE 34   Rest Of Europe Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)

TABLE 35   Rest Of Europe Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)

TABLE 36   Sleep Apnea Devices Market Analysis by Asia Pacific (USD Million), 2019 – 2028

TABLE 37   China Sleep Apnea Devices Market, 2019 – 2028 (USD Million)

TABLE 38   China Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)

TABLE 39   China Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)

TABLE 40   Japan Sleep Apnea Devices Market, 2019 – 2028 (USD Million)

TABLE 41   Japan Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)

TABLE 42   Japan Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)

TABLE 43   India Sleep Apnea Devices Market, 2019 – 2028 (USD Million)

TABLE 44   India Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)

TABLE 45   India Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)

TABLE 46   Rest of APAC Sleep Apnea Devices Market, 2019 – 2028 (USD Million)

TABLE 47   Rest of APAC Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)

TABLE 48   Rest of APAC Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)

TABLE 49   Sleep Apnea Devices Market Analysis by SAMEA (USD Million), 2019 – 2028

TABLE 50   Middle East & Africa (MEA) Sleep Apnea Devices Market, 2019 – 2028 (USD Million)

TABLE 51   Middle East & Africa (MEA) Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)

TABLE 52   Middle East & Africa (MEA) Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)

TABLE 53   South America Sleep Apnea Devices Market, 2019 – 2028 (USD Million)

TABLE 54   South America Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)

TABLE 55   South America Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)

TABLE 56   Rest Of World Sleep Apnea Devices Market, 2019 – 2028 (USD Million)

TABLE 57   Rest Of World Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)

TABLE 58   Rest Of World Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)

Request for Sample

Please fill out the form to receive sample pages of the report